Federal Jury in Dallas Finds Bard's IVC Blood Clot Filter Defective and Dangerous
Retrieved on:
Friday, July 23, 2021
Bard's IVC blood clot filter is defective and responsible for injuries and complications.
Key Points:
- Bard's IVC blood clot filter is defective and responsible for injuries and complications.
- The latest verdict for trial lawyers at Dallas-based Martin Baughman brings combined monetary awards to more than $7 million.
- In the Dallas case, jurors found that Bard's Recovery IVC filter caused serious medical complications when it fractured after being implanted.
- "We are very happy the jury held Bard accountable for Bard's misdeeds," said Charla Aldous of Aldous\Walker, Dallas, Texas, who tried the case with Mr. Martin in Dallas.